Geode Capital Management, LLC 4 D Molecular Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

  • $1.52 Trillion
  • Q3 2025

A detailed history of Geode Capital Management, LLC transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 913,519 shares of FDMT stock, worth $9.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
913,519
Previous 918,533 0.55%
Holding current value
$9.91 Million
Previous $3.41 Million 125.74%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
SELL
$3.95 - $8.44 $19,805 - $42,318
-5,014 Reduced 0.55%
913,519 $7.69 Million
Q2 2025

Aug 08, 2025
SELL
$2.51 - $4.79 $112,287 - $214,285
-44,736 Reduced 4.64%
918,533 $3.41 Million
Q1 2025

May 13, 2025
SELL
$3.23 - $6.6 $157,924 - $322,693
-48,893 Reduced 4.83%
963,269 $3.11 Million
Q4 2024

Feb 12, 2025
SELL
$5.3 - $10.41 $129,229 - $253,827
-24,383 Reduced 2.35%
1,012,162 $5.64 Million
Q3 2024

Nov 12, 2024
SELL
$10.81 - $27.22 $263,180 - $662,698
-24,346 Reduced 2.29%
1,036,545 $11.2 Million
Q2 2024

Aug 09, 2024
BUY
$20.93 - $30.01 $3.94 Million - $5.65 Million
188,228 Added 21.57%
1,060,891 $22.3 Million
Q1 2024

May 13, 2024
BUY
$17.03 - $35.87 $1.61 Million - $3.39 Million
94,501 Added 12.14%
872,663 $27.8 Million
Q4 2023

Feb 13, 2024
BUY
$9.76 - $21.25 $356,210 - $775,561
36,497 Added 4.92%
778,162 $15.8 Million
Q3 2023

Nov 13, 2023
BUY
$12.64 - $19.76 $655,864 - $1.03 Million
51,888 Added 7.52%
741,665 $9.44 Million
Q2 2023

Aug 11, 2023
BUY
$15.16 - $23.26 $1.7 Million - $2.6 Million
111,855 Added 19.35%
689,777 $12.5 Million
Q1 2023

May 15, 2023
BUY
$15.45 - $23.19 $250,058 - $375,330
16,185 Added 2.88%
577,922 $9.93 Million
Q4 2022

Feb 13, 2023
BUY
$6.85 - $25.46 $224,686 - $835,113
32,801 Added 6.2%
561,737 $12.5 Million
Q3 2022

Nov 14, 2022
BUY
$6.96 - $11.48 $251,332 - $414,554
36,111 Added 7.33%
528,936 $4.25 Million
Q2 2022

Aug 12, 2022
BUY
$5.68 - $15.99 $80,667 - $227,089
14,202 Added 2.97%
492,825 $3.44 Million
Q1 2022

May 13, 2022
SELL
$13.16 - $22.64 $50,192 - $86,348
-3,814 Reduced 0.79%
478,623 $7.24 Million
Q4 2021

Feb 11, 2022
BUY
$19.56 - $32.94 $2.74 Million - $4.62 Million
140,219 Added 40.97%
482,437 $10.6 Million
Q3 2021

Nov 12, 2021
BUY
$22.73 - $36.04 $3.97 Million - $6.3 Million
174,784 Added 104.39%
342,218 $9.23 Million
Q2 2021

Aug 13, 2021
BUY
$22.2 - $42.29 $469,219 - $893,841
21,136 Added 14.45%
167,434 $4.03 Million
Q1 2021

May 12, 2021
BUY
$35.94 - $52.67 $4.8 Million - $7.03 Million
133,518 Added 1044.74%
146,298 $6.35 Million
Q4 2020

Feb 12, 2021
BUY
$38.43 - $47.36 $491,135 - $605,260
12,780 New
12,780 $529,000

Others Institutions Holding FDMT

# of Institutions
137
Shares Held
40.5M
Call Options Held
70.6K
Put Options Held
13.1K
View Full List

About 4D Molecular Therapeutics, Inc.

FDMT Quotes by TradingView
  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $351M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email